OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Bulevirtide in the Treatment of Hepatitis Delta: Drug Discovery, Clinical Development and Place in Therapy
Vincent Soriano, Víctor Moreno‐Torres, Ana Treviño, et al.
Drug Design Development and Therapy (2023) Vol. Volume 17, pp. 155-166
Open Access | Times Cited: 15
Vincent Soriano, Víctor Moreno‐Torres, Ana Treviño, et al.
Drug Design Development and Therapy (2023) Vol. Volume 17, pp. 155-166
Open Access | Times Cited: 15
Showing 15 citing articles:
Effect of Peg-IFN on the viral kinetics of patients with HDV infection treated with bulevirtide
Selma El Messaoudi, Ségolène Brichler, Claire Fougerou‐Leurent, et al.
JHEP Reports (2024) Vol. 6, Iss. 8, pp. 101070-101070
Open Access | Times Cited: 6
Selma El Messaoudi, Ségolène Brichler, Claire Fougerou‐Leurent, et al.
JHEP Reports (2024) Vol. 6, Iss. 8, pp. 101070-101070
Open Access | Times Cited: 6
Prospects for Controlling Hepatitis B Globally
Vincent Soriano, Víctor Moreno‐Torres, Ana Treviño, et al.
Pathogens (2024) Vol. 13, Iss. 4, pp. 291-291
Open Access | Times Cited: 5
Vincent Soriano, Víctor Moreno‐Torres, Ana Treviño, et al.
Pathogens (2024) Vol. 13, Iss. 4, pp. 291-291
Open Access | Times Cited: 5
Clinical Pharmacology of Bulevirtide: Focus on Known and Potential Drug–Drug Interactions
Martina Billi, Sara Soloperto, Stefano Bonora, et al.
Pharmaceutics (2025) Vol. 17, Iss. 2, pp. 250-250
Open Access
Martina Billi, Sara Soloperto, Stefano Bonora, et al.
Pharmaceutics (2025) Vol. 17, Iss. 2, pp. 250-250
Open Access
Current prevalence of hepatitis delta diagnosis in Valencia, Spain
E Ortega-González, Dolores Ocete, María Martínez-Roma, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
E Ortega-González, Dolores Ocete, María Martínez-Roma, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Nanoparticle-based therapeutic strategies for chronic liver diseases: Advances and insights
Padmanaban Sathiyamoorthy, Jiwon Baek, Sai Sahithya Chamarthy, et al.
Liver Research (2025)
Open Access
Padmanaban Sathiyamoorthy, Jiwon Baek, Sai Sahithya Chamarthy, et al.
Liver Research (2025)
Open Access
Consensus Guidelines: Best Practices for the Prevention, Detection and Management of Hepatitis B Virus Reactivation in Clinical Trials with Immunosuppressive/Immunomodulatory Therapy
E. Cohen, Arie Regev, Anju Garg, et al.
Drug Safety (2024) Vol. 47, Iss. 4, pp. 321-332
Open Access | Times Cited: 3
E. Cohen, Arie Regev, Anju Garg, et al.
Drug Safety (2024) Vol. 47, Iss. 4, pp. 321-332
Open Access | Times Cited: 3
Bile Acid Signaling in Metabolic and Inflammatory Diseases and Drug Development
Tiangang Li, John Y.L. Chiang
Pharmacological Reviews (2024) Vol. 76, Iss. 6, pp. 1221-1253
Closed Access | Times Cited: 3
Tiangang Li, John Y.L. Chiang
Pharmacological Reviews (2024) Vol. 76, Iss. 6, pp. 1221-1253
Closed Access | Times Cited: 3
Viral hepatitis in persons living with HIV in the post-COVID era
Vincent Soriano, Víctor Moreno‐Torres, Carmen de Mendoza, et al.
Aids Reviews (2023) Vol. 25, Iss. 1
Open Access | Times Cited: 8
Vincent Soriano, Víctor Moreno‐Torres, Carmen de Mendoza, et al.
Aids Reviews (2023) Vol. 25, Iss. 1
Open Access | Times Cited: 8
The Forgotten Virus, Hepatitis D: A Review of Epidemiology, Diagnosis, and Current Treatment Strategies
Adam Khattak, Tahne Vongsavath, Lubaba Haque, et al.
Journal of Clinical and Experimental Hepatology (2024) Vol. 14, Iss. 5, pp. 101395-101395
Closed Access | Times Cited: 2
Adam Khattak, Tahne Vongsavath, Lubaba Haque, et al.
Journal of Clinical and Experimental Hepatology (2024) Vol. 14, Iss. 5, pp. 101395-101395
Closed Access | Times Cited: 2
Long‐Term Treatment with Bulevirtide in Patients with Chronic Hepatitis D and Advanced Chronic Liver Disease
Ayaz Sapuk, Leonie Steinhoff, Kristin Huenninghaus, et al.
Canadian Journal of Gastroenterology and Hepatology (2024) Vol. 2024, Iss. 1
Open Access | Times Cited: 2
Ayaz Sapuk, Leonie Steinhoff, Kristin Huenninghaus, et al.
Canadian Journal of Gastroenterology and Hepatology (2024) Vol. 2024, Iss. 1
Open Access | Times Cited: 2
Prevalence, clinical and virological characteristics and short‐term prognosis of hepatitis delta infection among patients with HIV/HBV in Nouakchott, Mauritania
Hélène Le Guillou‐Guillemette, Adeline Pivert, Ahmed Elbara, et al.
Journal of Viral Hepatitis (2024) Vol. 31, Iss. 8, pp. 457-465
Closed Access | Times Cited: 1
Hélène Le Guillou‐Guillemette, Adeline Pivert, Ahmed Elbara, et al.
Journal of Viral Hepatitis (2024) Vol. 31, Iss. 8, pp. 457-465
Closed Access | Times Cited: 1
Emerging drugs for hepatitis D
Onur Keskın, Cihan Yurdaydìn
Expert Opinion on Emerging Drugs (2023) Vol. 28, Iss. 2, pp. 55-66
Closed Access | Times Cited: 2
Onur Keskın, Cihan Yurdaydìn
Expert Opinion on Emerging Drugs (2023) Vol. 28, Iss. 2, pp. 55-66
Closed Access | Times Cited: 2
Recent Trends in Peptide Drug Discovery and Development
Harrison Y. R. Madge, Markus Muttenthaler
Royal Society of Chemistry eBooks (2024), pp. 23-49
Closed Access
Harrison Y. R. Madge, Markus Muttenthaler
Royal Society of Chemistry eBooks (2024), pp. 23-49
Closed Access
Prevalence and determinants of hepatitis delta virus infection among HIV /hepatitis B‐coinfected adults in care in the United States
Nicole Ferrante, Michael J. Kallan, Sophia Sukkestad, et al.
Journal of Viral Hepatitis (2023) Vol. 30, Iss. 11, pp. 879-888
Closed Access | Times Cited: 1
Nicole Ferrante, Michael J. Kallan, Sophia Sukkestad, et al.
Journal of Viral Hepatitis (2023) Vol. 30, Iss. 11, pp. 879-888
Closed Access | Times Cited: 1
Pegylated interferon in the treatment of chronic delta hepatitis: the experience from real-world clinical practice
S.A. Magomedova, Saida K. Bilalova, Khatuna Dzhemalievna Peradze, et al.
Almanac of Clinical Medicine (2023) Vol. 51, Iss. 4, pp. 227-235
Open Access
S.A. Magomedova, Saida K. Bilalova, Khatuna Dzhemalievna Peradze, et al.
Almanac of Clinical Medicine (2023) Vol. 51, Iss. 4, pp. 227-235
Open Access
